- Report
- May 2024
- 93 Pages
Global
From €4471EUR$4,995USD£3,906GBP
- Report
- May 2024
- 291 Pages
Global
From €4471EUR$4,995USD£3,906GBP
- Report
- January 2024
- 182 Pages
Global
€4471EUR$4,995USD£3,906GBP
- Report
- November 2023
- 309 Pages
Global
€4471EUR$4,995USD£3,906GBP
- Report
- November 2023
- 246 Pages
Global
€4471EUR$4,995USD£3,906GBP
- Report
- November 2023
- 250 Pages
Global
€4471EUR$4,995USD£3,906GBP
- Report
- July 2023
- 220 Pages
Global
€4113EUR$4,595USD£3,593GBP
- Report
- March 2025
- 142 Pages
Global
From €3536EUR$3,950USD£3,088GBP
- Report
- January 2025
- 140 Pages
Global
From €3536EUR$3,950USD£3,088GBP
- Report
- January 2025
- 146 Pages
Global
From €3536EUR$3,950USD£3,088GBP
- Report
- August 2024
- 140 Pages
Global
From €3536EUR$3,950USD£3,088GBP
- Report
- April 2024
- 114 Pages
Global
From €3536EUR$3,950USD£3,088GBP
- Report
- April 2024
- 140 Pages
Global
From €3536EUR$3,950USD£3,088GBP
- Report
- April 2024
- 114 Pages
Global
From €3536EUR$3,950USD£3,088GBP
- Report
- April 2024
- 130 Pages
Global
From €3804EUR$4,250USD£3,323GBP
- Report
- January 2024
- 148 Pages
Global
From €3804EUR$4,250USD£3,323GBP
- Report
- January 2024
- 140 Pages
Global
From €3804EUR$4,250USD£3,323GBP
- Report
- December 2023
- 145 Pages
Global
From €3983EUR$4,450USD£3,479GBP
- Report
- December 2023
- 145 Pages
Global
From €3983EUR$4,450USD£3,479GBP
- Report
- November 2023
- 140 Pages
Global
From €3983EUR$4,450USD£3,479GBP

The biotechnology Research and Development (R&D) market is a rapidly growing sector of the biotechnology industry. It involves the development of new products and technologies, as well as the improvement of existing ones. Companies in this market are typically focused on the development of new drugs, diagnostics, medical devices, and other biotechnological products. They also conduct research into the biological processes and mechanisms that underlie diseases and other medical conditions.
R&D in biotechnology is often conducted in collaboration with universities, government agencies, and other organizations. This collaboration allows for the sharing of resources and expertise, and helps to ensure that the latest technologies and discoveries are being used.
Some of the major companies in the biotechnology R&D market include Amgen, Biogen, Gilead Sciences, Johnson & Johnson, Merck, Novartis, Pfizer, and Roche. These companies are involved in the development of new drugs, diagnostics, and medical devices, as well as the improvement of existing ones. They also conduct research into the biological processes and mechanisms that underlie diseases and other medical conditions. Show Less Read more